Cancer clinical trials in the region Occitanie

174 currently recruiting clinical trials
Region Occitanie

Phase 2 Lung cancer
#NCT05118789
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic ROS-1 Targeted therapy 1 2 3 or more
Systemic Treatment-Naive
7 main criterias to confirm
Centre Hospitalier Universitaire de Toulouse (Toulouse)
Nuvalent Inc.
Phase 2 Lung cancer
#NCT05118789
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic ROS-1 Systemic Treatment-Naive Immunotherapy Chemotherapy None 1
Targeted therapy
7 main criterias to confirm
Centre Hospitalier Universitaire de Toulouse (Toulouse)
Nuvalent Inc.
Phase 2 Kidney cancer
#NCT05096390
Other Locally Advanced Metastatic Systemic Treatment-Naive Systemic Treatment-Naive None
6 main criterias to confirm
IUCT Oncopôle (Toulouse)
Centre Léon Bérard
Phase 2 Pancreas cancer
#NCT05065801
Adenocarcinoma Metastatic Systemic Treatment-Naive None
Surgery Chemotherapy Radiotherapy Radiochemotherapy
6 main criterias to confirm
Centre Hospitalier de Perpignan (Perpignan), Institut du cancer de Montpellier (Montpellier), Centre Hospitalier Universitaire de Montpellier - Site de Saint Eloi (Montpellier)
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 2 Liver and bile duct cancer
#NCT05063565
Hepatocellular carcinoma Localized Systemic Treatment-Naive None Unhealthy A
Immunotherapy Radiotherapy
8 main criterias to confirm
Centre Hospitalier Universitaire de Montpellier - Site Arnaud de Villeneuve (Montpellier)
Boston Scientific Corporation
Phase 2 Breast cancer
#NCT04985266
HER2 Negative HR Positive Localized Surgery Chemotherapy Hormone therapy None
Targeted therapy
7 main criterias to confirm
IUCT Oncopôle (Toulouse), Institut Sainte Catherine (Avignon)
Fiducie de la Fondation Royal Marsden NHS
Phase 2 Lung cancer
#NCT04956640
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic KRAS G12C Systemic Treatment-Naive
5 main criterias to confirm
IUCT Oncopôle (Toulouse), Institut du cancer de Montpellier (Montpellier)
Eli Lilly et compagnie
Phase 2 Colon cancer Rectal cancer Anal cancer
#NCT04954820
Neuroendocrine tumor 1
Systemic Treatment-Naive Systemic Treatment-Naive
5 main criterias to confirm
IUCT Oncopôle (Toulouse), Institut du cancer de Montpellier (Montpellier)
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 2 Colon cancer Rectal cancer
#NCT04730544
Locally Advanced Metastatic MSI/dMMR None 1
MSS Immunotherapy Bispecific T-cell engager antibodies Immunotherapy Bispecific T-cell engager antibodies
7 main criterias to confirm
Centre Hospitalier Universitaire de Toulouse (Toulouse), Institut du cancer de Montpellier (Montpellier), Institut Sainte Catherine (Avignon)
GERCOR - Groupe Coopératif Multidisciplinaire d'Oncologie
Phase 2 Liver and bile duct cancer
#NCT04727307
Hepatocellular carcinoma Localized Systemic Treatment-Naive None Unhealthy A
Surgery Transplant
8 main criterias to confirm
Centre Hospitalier de Perpignan (Perpignan), Centre Hospitalier Universitaire de Montpellier - Site Arnaud de Villeneuve (Montpellier), Centre Hospitalier Universitaire de Nîmes (Nîmes)
CHU de Montpellier